Company intelligence / Profile preview

SkeleTech

Bothell, Washington, USA

Ownership: Private
Employees: ~60
Development stage: Other

Overview

SkeleTech was a specialized contract research organization (CRO) focused on bone biology and skeletal diseases. Founded in 1998 and headquartered in Bothell, Washington, the company provided preclinical and clinical research services to pharmaceutical and biotechnology companies. Their expertise included bone histomorphometry, biomechanical testing, and various animal models for osteoporosis and fracture healing. SkeleTech was acquired by Cambrex Corporation in 2003 to bolster its biopharma services division and was later integrated into Lonza following Cambrex's divestiture of its bioproducts business.

Therapeutic areas: OncologyEndocrinologyRheumatology
Modalities: Small moleculeRecombinant protein
Industry: Contract Research Organization

Partnerships

AmgenEli LillyMerckProcter & Gamble

Beyond the preview

Go deeper on SkeleTech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkeleTech.

Explore the full profile